Arteritis after administration of granulocyte colony-stimulating factor: a case series
Granulocyte colony-stimulating factor (G-CSF) is commonly administered to prevent serious complications caused by chemotherapy-induced neutropenia; however, several cases of arteritis following the administration of G-CSF have been reported. Here, we report three cases of patients with non-Hodgkin lymphomas (NHLs) who developed arteritis after the administration of G-CSF, estimate the probability of adverse drug reaction caused by G-CSF with two distinct algorithms, and review the literatures. Both algorithms indicated a causal relationship between G-CSF and arteritis. In a literature review of seven reported cases, including our three patients, the time from the administration of G-CSF to the onset of arteritis ranged from 9 days to 6 months, and five patients were treated with steroids. In one of our three cases, a 62-year-old female with NHL developed arteritis twice in different courses of chemotherapy. Hydrocortisone was administered in the second event, leading to prompt relief of the manifestation and abnormal laboratory data. This finding suggests steroids may be effective for arteritis. In conclusion, although the number of reported cases is limited, there appears to be an association between arteritis and the administration of G-CSF, and steroids are an effective therapeutic option.
KeywordsGranulocyte colony-stimulating factor (G-CSF) Arteritis Lymphoma
Compliance with ethical standards
Conflict of interest
Mineo Kurokawa: Dr. Kurokawa reports grants from Pfizer Seiyaku K.K, grants from Astellas Pharma, grants from Kyowa Hakko Kirin Co., Ltd., Grants from Takeda Pharmaceutical Company Limited., Grants from ONO PHARMACEUTICAL CO., LTD., Grants from Nippon Shinyaku Co., Ltd., Grants from Bristol-Meyer Squib, grants from Novartis Pharmaceuticals, other from Shionogi & Co., Ltd, other from Celgene K.K., outside the submitted work; Masashi Miyauchi: Dr. Miyauchi reports Grants from Kyowa Hakko Kirin Co., Ltd.
- 3.Ito Y, Noda K, Aiba K, Yano S, Fujii T. Diffuse large B-cell lymphoma complicated with drug-induced vasculitis during administration of pegfilgrastim. Rinsho Ketsueki. 2017;58:2238–42.Google Scholar
- 4.Rosenberg SA. Validity of the Ann Arbor staging classification for the non-Hodgkin’s lymphomas. Cancer Treat Rep. 1977;61:1023–7.Google Scholar